These 5 trends are shaping the UK biopharma investment landscape
The UK needs to move away from having lots of early-stage biotech companies towards supporting the development of firms through to later-stage.
The UK needs to move away from having lots of early-stage biotech companies towards supporting the development of firms through to later-stage.
Unless you are a serial entrepreneur, you have probably never negotiated a term sheet or had to think about building enterprise value. In fact, running a company will require competencies new to you, and some of those competencies will flow directly from the funding you receive. In this blog, I’d like to discuss some of […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Fundraising is one of the most challenging aspects in your role as an entrepreneur. There are a myriad of options available to finance your business and enable its growth from an initial idea through to a business success story. There is much to think about in choosing the right partner. In this blog, I address […]